Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cartilage-associated protein (CRTAP) is a non-enzymatic structural and scaffolding protein, closely related to the Leprecan family, and is encoded by the CRTAP gene in humans. CRTAP forms a complex in the endoplasmic reticulum with prolyl 3-hydroxylase 1 (P3H1/LEPRE1) and cyclophilin B (PPIB). This complex is essential for the 3-hydroxylation of proline residues in fibrillar collagens (types I, II, and V), a post-translational modification necessary for proper collagen folding, stability, and extracellular matrix organization. CRTAP mutations cause specific recessive forms of osteogenesis imperfecta, a disease characterized by bone fragility, low bone mass, and connective tissue abnormalities. CRTAP itself is not a classical druggable therapeutic target (e.g., enzyme, receptor, transporter), and there are no known drugs that interact directly with it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cartilage-associated protein (CRTAP).